Neurology:动脉瘤性蛛网膜下腔出血后癫痫

2015-06-08 李志行 译 MedSci原创

我们的研究目的为通过一基于人口的队列研究进而阐明来源于囊性颅内动脉瘤(sIA)的动脉瘤性蛛网膜下腔出血(SAH)后癫痫的发病率以及危险因素。研究方法:Kuopio sIA数据库包括Kuopio大学医院收治的东芬兰地区所有未破裂和破裂的sIA病例。处方药的应用包括可报销的抗癫痫药,此类药已经进入芬兰国家注册。我们分析了自1995年至2007年876位sIA-SAH患者的癫痫以及死亡的累积发病率和独立

我们的研究目的为通过一基于人口的队列研究进而阐明来源于囊性颅内动脉瘤(sIA)的动脉瘤性蛛网膜下腔出血(SAH)后癫痫的发病率以及危险因素。

研究方法:


Kuopio sIA数据库包括Kuopio大学医院收治的东芬兰地区所有未破裂和破裂的sIA病例。处方药的应用包括可报销的抗癫痫药,此类药已经进入芬兰国家注册。我们分析了自1995年至2007年876位sIA-SAH患者的癫痫以及死亡的累积发病率和独立的危险因素。应用竞争风险分析来准确评估发生癫痫的可能性,因为sIA-SAH后癫痫以及死亡可能存在共同的危险因素。

研究结果:

随访终止于研究对象(n = 200) 的死亡或直到2008年12月31日,随访中点为76个月,在发生sIA-SAH后8个月期间有113位患者被诊断为癫痫。sIA-SAH后1年,癫痫的累计发病率为8%,5年时为12%。颅内出血(ICH)>15cm3的患者,有33%进展为癫痫。876位sIA-SAH患者中,关于癫痫的独立危险因素为ICH >15cm3、Hunt-Hess分级III–V级以及急性癫痫发作等。

研究结论:

癫痫的5年累计发病率为12%。sIA-SAH后12个月死亡率和癫痫存在共同的独立危险因素。可以利用大脑组织的基本损伤征象来预测sIA-SAH幸存者两周内癫痫的发生,其中最显著的为ICH。

原始出处:

Huttunen J1, Kurki MI2, von Und Zu Fraunberg M2, Koivisto T2, Ronkainen A2, Rinne J2, Jääskeläinen JE2, Kälviäinen R2, Immonen A2.Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study.Neurology. 2015 Jun 2;84(22):2229-37. doi: 10.1212/WNL.0000000000001643. Epub 2015 May 6.

本文是MedSci原创编译整理,转载请注明来源并附原文链接。谢谢!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999531, encodeId=747c19995310e, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 07 01:04:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654409, encodeId=4e8e1654409d5, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Fri Oct 23 16:04:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30452, encodeId=6a023045229, content=12年的回顾性队列研究,好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51b9105133, createdName=qing1231990, createdTime=Sat Jul 04 11:20:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27601, encodeId=89412e60158, content=有点东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efcb1614039, createdName=qinweihan19, createdTime=Sun Jun 14 16:17:00 CST 2015, time=2015-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337783, encodeId=1cc1133e78315, content=<a href='/topic/show?id=376c332e497' target=_blank style='color:#2F92EE;'>#动脉瘤性蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33274, encryptionId=376c332e497, topicName=动脉瘤性蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Wed Jun 10 10:04:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26668, encodeId=2f9d2666863, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:12:00 CST 2015, time=2015-06-09, status=1, ipAttribution=)]
    2015-10-07 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999531, encodeId=747c19995310e, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 07 01:04:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654409, encodeId=4e8e1654409d5, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Fri Oct 23 16:04:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30452, encodeId=6a023045229, content=12年的回顾性队列研究,好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51b9105133, createdName=qing1231990, createdTime=Sat Jul 04 11:20:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27601, encodeId=89412e60158, content=有点东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efcb1614039, createdName=qinweihan19, createdTime=Sun Jun 14 16:17:00 CST 2015, time=2015-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337783, encodeId=1cc1133e78315, content=<a href='/topic/show?id=376c332e497' target=_blank style='color:#2F92EE;'>#动脉瘤性蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33274, encryptionId=376c332e497, topicName=动脉瘤性蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Wed Jun 10 10:04:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26668, encodeId=2f9d2666863, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:12:00 CST 2015, time=2015-06-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999531, encodeId=747c19995310e, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 07 01:04:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654409, encodeId=4e8e1654409d5, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Fri Oct 23 16:04:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30452, encodeId=6a023045229, content=12年的回顾性队列研究,好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51b9105133, createdName=qing1231990, createdTime=Sat Jul 04 11:20:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27601, encodeId=89412e60158, content=有点东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efcb1614039, createdName=qinweihan19, createdTime=Sun Jun 14 16:17:00 CST 2015, time=2015-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337783, encodeId=1cc1133e78315, content=<a href='/topic/show?id=376c332e497' target=_blank style='color:#2F92EE;'>#动脉瘤性蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33274, encryptionId=376c332e497, topicName=动脉瘤性蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Wed Jun 10 10:04:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26668, encodeId=2f9d2666863, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:12:00 CST 2015, time=2015-06-09, status=1, ipAttribution=)]
    2015-07-04 qing1231990

    12年的回顾性队列研究,好东西

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1999531, encodeId=747c19995310e, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 07 01:04:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654409, encodeId=4e8e1654409d5, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Fri Oct 23 16:04:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30452, encodeId=6a023045229, content=12年的回顾性队列研究,好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51b9105133, createdName=qing1231990, createdTime=Sat Jul 04 11:20:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27601, encodeId=89412e60158, content=有点东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efcb1614039, createdName=qinweihan19, createdTime=Sun Jun 14 16:17:00 CST 2015, time=2015-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337783, encodeId=1cc1133e78315, content=<a href='/topic/show?id=376c332e497' target=_blank style='color:#2F92EE;'>#动脉瘤性蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33274, encryptionId=376c332e497, topicName=动脉瘤性蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Wed Jun 10 10:04:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26668, encodeId=2f9d2666863, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:12:00 CST 2015, time=2015-06-09, status=1, ipAttribution=)]
    2015-06-14 qinweihan19

    有点东西

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1999531, encodeId=747c19995310e, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 07 01:04:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654409, encodeId=4e8e1654409d5, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Fri Oct 23 16:04:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30452, encodeId=6a023045229, content=12年的回顾性队列研究,好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51b9105133, createdName=qing1231990, createdTime=Sat Jul 04 11:20:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27601, encodeId=89412e60158, content=有点东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efcb1614039, createdName=qinweihan19, createdTime=Sun Jun 14 16:17:00 CST 2015, time=2015-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337783, encodeId=1cc1133e78315, content=<a href='/topic/show?id=376c332e497' target=_blank style='color:#2F92EE;'>#动脉瘤性蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33274, encryptionId=376c332e497, topicName=动脉瘤性蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Wed Jun 10 10:04:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26668, encodeId=2f9d2666863, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:12:00 CST 2015, time=2015-06-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1999531, encodeId=747c19995310e, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 07 01:04:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654409, encodeId=4e8e1654409d5, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Fri Oct 23 16:04:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30452, encodeId=6a023045229, content=12年的回顾性队列研究,好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51b9105133, createdName=qing1231990, createdTime=Sat Jul 04 11:20:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27601, encodeId=89412e60158, content=有点东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efcb1614039, createdName=qinweihan19, createdTime=Sun Jun 14 16:17:00 CST 2015, time=2015-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337783, encodeId=1cc1133e78315, content=<a href='/topic/show?id=376c332e497' target=_blank style='color:#2F92EE;'>#动脉瘤性蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33274, encryptionId=376c332e497, topicName=动脉瘤性蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Wed Jun 10 10:04:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26668, encodeId=2f9d2666863, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:12:00 CST 2015, time=2015-06-09, status=1, ipAttribution=)]
    2015-06-09 huaxipanxing

    看看

    0

相关资讯

WEMU = 衬衫加帽子 = 拯救癫痫病人

当谈到可穿戴设备,大多数人能想到的都是智能手环,例如Jawbone Up亦或者Misfit Flash。的确它们现在很火热,并且也深受消费者们的喜爱。不过当智能手环已经成为“街机标配”之后,对于医疗健康类的可穿戴设备,我们还应该期待什么?比如说,一件能拯救个体生命的“智能衬衫”。 创业公司BioSerenity发明了一款名为WEMU的智能衬衫,它的全称“Wearable Epilepsy Mon

FDA发布警告,辉瑞戒烟药物Chantix可能诱发癫痫

美国FDA近日发布警告声明称,辉瑞的戒烟药物Chantix可能与癫痫发作有关。服药的病人若同时有酒精摄入,就可能会变得情绪激动或是诱发癫痫。 FDA表示,尽管在九月份就已经更新了产品说明书,但是现在发布声明是为了让患者重视这一变化,从而在医生开处方的时候加以考虑。 通常在药品标签变更的同时会做出这样的警告声明。 Chantix的化学名称是varenicline,是2006年批准的

Nat Med:治疗癫痫新策略!

近日,来自北海道大学等处的研究人员通过研究揭示了引发常染色体显性侧颞叶癫痫(ADLTE)的特殊蛋白的构象缺失,ADLTE是一种家族性癫痫形式,研究者揭示,利用一种特殊的化学分子伴侣就可以通过修正蛋白的缺失从而有效改善患人类癫痫的小鼠模型的癫痫敏感性的增加,相关研究刊登于国际杂志Nature Medicine上。 文章中,研究者Masaki Fukata教授表示,编码分泌蛋白的基因LGI1的突变会

Lancet社论:为癫痫患者发声

2015年2月9日是首个国际癫痫病日。这是在国际癫痫局(IBE)和国际抗癫痫病联盟(ILAE)共同的努力之下所设立的。国际癫痫病日是为了引起公众对癫痫病的关注并且鼓励大家对癫痫病进行讨论。这样的努力是迫切需要的,因为全球范围内有超过5000万人患有癫痫病,其中75%的患者生活在低收入国家。2013年,119000人由于癫痫发病而丧生。只有另外一种疾病(HIV感染)比不受控制的、剧烈的癫痫造成了

综述:癫痫持续状态的诊疗进展

传统认为癫痫持续状态(SE)是指任何类型的单次癫痫发作或反复癫痫发作持续30min及以上,发作间期意识状态未完全恢复。然而随着研究的深入,人们意识到早在癫痫发作起始5~10min时,神经功能已经出现不可逆损伤,且临床操作中早期快速终止SE发作可明显改善患者预后。目前数据显示,极少数癫痫发作或脑电图的痫样放电会持续超过5min,且超过5min的发作大多不会自行停止。动物实验表明,早于SE发作30

JAMA Neurol:癫痫持续状态住院和死亡率评估

 癫痫持续状态是一种相当常见的神经学紧急状况,每十万人中每年发病人数为10-41人。无显著特点的抽搐癫痫持续状态是最严重的、最常见的一种癫痫持续状态。癫痫持续状态和发病率、死亡率以及医疗花费都有关。但是与癫痫持续状态相关的住院治疗状况和死亡率的具体数据有限。30%的病人最终被检测为患有癫痫的患者起初呈现为癫痫持续状态。来自NIS的1999年至2010年的数据被用来估计癫痫持续状态的住院治